Mick Mulvaney: Stop Calling It a Prediction Market
Former official presses lawmakers to reclassify online event markets, arguing they are sports betting. The move inten...
Which Rewards Card Is Better For Travel
Which rewards card is better for travel? Explore options to maximize your travel benefits and choose the right card for you.
22,786 articles
Planet Labs Jumps After Hours as Backlog Surges Past $900M
Planet Labs reports a record Q4 revenue and a backlog eclipsing annual sales, spurring a sharp after hours rally as i...
Fed Rate Hikes Debate, Credit Tightening Sparks Markets
Credit conditions are tightening ahead of any Fed move, driven by higher bond yields and a wave of AI financing. Inve...
Rex 2025 Earnings Call: A Practical Deep Dive for Investors
As Rex gears up to report Q4 2025 results, investors should focus on growth drivers, margins, and the outlook. This g...
More Than Half Industry Sectors in Correction, S&P Outlook
March’s selling surge has left more than half industry sectors mired in correction territory, prompting fresh bets on...
Best Obesity Stock Hold for Safe GLP-1 Drug Exposure
Investing in obesity drugs doesn't have to be a gamble. This guide explains why a proven company with real cash flow ...
Bitcoin Hantavirus: Bracing Another Black Swan Shock
As a global health scare rises in prominence, investors quiz whether bitcoin can withstand another black swan shock. ...
These Forces Could Push Bitcoin Higher This Week
Bitcoin steadies as US-Iran tensions ripple through oil and inflation bets. Analysts say these forces could push BTC ...
Altman Defends Himself as Honest Leader in OpenAI Trial
OpenAI CEO Sam Altman faces cross-examination in a federal court case brought by Elon Musk, defending his leadership ...
The Lithium Gold Rush Just Minted a Unicorn This Year
A lithium-focused startup has joined the unicorn club after a surge in demand for EV batteries. The move signals a br...
Low-Cost Europe, Japan Stocks Draw Investors in 2026
As U.S. markets face volatility, a single low-cost ETF offering broad exposure to Europe and Japan is drawing steady ...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status